Patent ID: 11951038
Assignee: MATI THERAPEUTICS INC.
Field: Medical technology (Instruments)
Classification: CPC A  Y | IPC A

Claim 1:
2. The kit of claim 1, wherein the therapeutic agent is selected from the group consisting of thrombin inhibitors; antithrombogenic agents; thrombolytic agents; fibrinolytic agents; vasospasm inhibitors; vasodilators; antihypertensive agents; antimicrobial agents; antibiotic agents; antifungal agents; antiviral agents; inhibitors of surface glycoprotein receptors; antiplatelet agents; antimitotics; microtubule inhibitors; anti-secretory agents; active inhibitors; remodeling inhibitors; antisense nucleotides; anti-metabolites; antiproliferatives; anticancer chemotherapeutic agents; anti-inflammatories; non-steroidal anti-inflammatories (NSAIDs); prostaglandins, prostaglandin analogues, antiprostaglandins, prostaglandin precursors, acetazolamide, dorzolamide, brinzolamide, methazolamide, dichlorphenamide, diamox; lubezole, nimodipine, pilocarpine, carbachol, physostigmine and combinations thereof.